Primary biliary cirrhosis: modalities of injury and death in biliary epithelium.
OBJECTIVE
Despite the number of studies on primary biliary cirrhosis, contrasting data remain concerning modalities of cholangiocyte death. Liver biopsies obtained from 40 patients with anti mitochondrial antibody-positive primary biliary cirrhosis, at various stages of the disease, were examined, and special attention was paid to the expression of subcellular damage and evidence of apoptosis.


METHODS
Liver sections were stained with haematoxylin/eosin or Sirius red. Ductular mass was evaluated on sections after cytokeratin 7 staining. Apoptosis was evaluated on haematoxylin/eosin stained material or after processing for terminal deoxynucleotidyl transferase-mediated dUTP nick end-labelling assay. In 16 patients, part of the biopsy was processed for electron microscopy. Twenty histologically normal liver biopsies were used for control purposes.


RESULTS
According to Scheuer's classification, 29 patients were classified as stage I-II, and 11 as stage III-IV. A strong staining of bile ducts was evident after immunohistochemistry for cytokeratin 7, often associated with ductular metaplasia in lobular zone 1. Cytokeratin 7-positive cells occupied 3.0+/-1.3% of liver mass as compared to 0.25+/-0.03% in controls. Ductular metaplasia accounted for 1.4+/-0.07% of all cytokeratin 7-positive cells. Regardless of staging, apoptotic bodies were seen only exceptionally in epithelial wall of bile ducts, whereas cholangiocyte damage leading to extensive lytic necrosis appeared responsible for most of the bile duct mass loss, as also confirmed by ultrastructural studies. A few terminal deoxynucleotidyl transferase-mediated dUTP nick end-labelling-positive nuclei were occasionally associated with the inflammatory infiltrate and evidence of apoptosis in hepatocytes was frequent, especially in zone 1.


CONCLUSIONS
Regardless of staging, lytic necrosis and not apoptosis accounts for most of the bile duct loss in primary biliary cirrhosis. Furthermore, ductular metaplasia appears as a late event with highly variable pattern being observed between patients.
Marucci
L
L
Department of Gastroenterology, University of Ancona, Italy.
Ugili
L
L
Macarri
G
G
Feliciangeli
G
G
Bendia
E
E
Jezequel
A M
AM
Orlandi
F
F
Benedetti
A
A
D017209:Apoptosis; D001652:Bile Ducts / Q000473:pathology / Q000503:physiopathology* / Q000648:ultrastructure; D015415:Biomarkers / Q000032:analysis; D001706:Biopsy / Q000379:methods; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D053552:Keratin-7; D007633:Keratins / Q000032:analysis*; D008105:Liver Cirrhosis, Biliary / Q000473:pathology / Q000503:physiopathology*; D008297:Male; D008854:Microscopy, Electron
D015415:Biomarkers; C507497:KRT7 protein, human; D053552:Keratin-7; D007633:Keratins